Doctors test custom treatment to shrink breast tumors before surgery
NCT ID NCT07300215
Summary
This study aims to find better personalized treatment plans for patients with a specific type of breast cancer (HR+/HER2+) before they have surgery. Researchers will test different drug combinations based on how patients initially respond to treatment, with the goal of shrinking tumors more effectively. The study will involve 60 female participants and will monitor how well the tumors respond and the safety of the treatment approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.